tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Rebecca Liang, 1 are a BUY (25%), 3 are a HOLD (75%).
Analyst Rebecca Liang, currently employed at BERNSTEIN, carries an average stock price target met ratio of 75% that have a potential upside of 7.21% achieved within 18 days.
Rebecca Liang’s has documented 8 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BGNE, BeiGene Ltd at 29-Nov-2024.
Analyst best performing recommendations are on BGNE (BEIGENE LTD).
The best stock recommendation documented was for BGNE (BEIGENE LTD) at 11/29/2024. The price target of $207 was fulfilled within 3 days with a profit of $8 (3.72%) receiving and performance score of 12.4.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 25-Feb-2019
$260
$75.29 (40.76%)
$260
1 years 10 months 5 days ago
(17-Dec-2024)
7/13 (53.85%)
$80.94 (45.20%)
148
Buy Since 03-Dec-2024
$300
$115.29 (62.42%)
1 years 10 months 19 days ago
(03-Dec-2024)
0/1 (0%)
$93.99 (45.62%)
Hold Since 29-Jun-2023
$207
$22.29 (12.07%)
$161
1 years 10 months 23 days ago
(29-Nov-2024)
3/4 (75%)
$-8 (-3.72%)
18
Buy Since 20-Aug-2024
$235
$50.29 (27.23%)
$200
2 years ago
(22-Oct-2024)
4/5 (80%)
$14.37 (6.51%)
130
Buy Since 14-May-2019
$307
2 years 1 months 26 days ago
(26-Aug-2024)
12/24 (50%)
$113.18 (58.39%)
58
What Year was the first public recommendation made by Rebecca Liang?
